Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?

Burkhardt, Olaf

Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? [electronic resource] - The Journal of antimicrobial chemotherapy Oct 2006 - 822-9 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

0305-7453

10.1093/jac/dkl328 doi


Adult
Anti-Bacterial Agents--administration & dosage
Cystic Fibrosis--drug therapy
Drug Resistance, Bacterial
Female
Humans
Male
Microbial Sensitivity Tests
Pseudomonas Infections--drug therapy
Pseudomonas aeruginosa--drug effects
Respiratory Function Tests
Tobramycin--administration & dosage
Treatment Outcome